ConnectM Technology Solutions, Inc. (Nasdaq: CNTM) ("ConnectM" or the "Company"), a high-growth technology company on the leading edge of the energy economy, today announced that it has received a non ...

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

Leveraging Infosys Topaz, the Stats Center offers interactive and immersive stories based on driver and team stats across ...

Last week, after Musk saw a huge drop in a single day (not unrelated to the market-wide fall caused by Trump’s tariffs and ...

Valens Semiconductor (NYSE: VLN) ('Valens'), a leader in high-performance connectivity, announced today that Valens' VA7000 MIPI A-PHY-compliant chipsets will form the in-car, sensor to compute ...

According to an attorney for a detained Venezuelan asylum-seeker, her client’s deportation was justified because he had a ...

MaxLinear will be highlighting the performance of Rushmore across multiple applications in its private demo area at the ...

CAUTION: Federal (USA) law restricts these devices for sale or use by or on the order of a physician.

(ARTMS), a global leader in radioisotope production technologies, is pleased to announce that the drug master file (DMF) 1 ...

One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...

We are also pleased to share our new logo, which we intend to adopt after the name change ... cause actual results to differ ...